Related Experiment Video
Updated: Jun 20, 2026

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
From trial-and-error to inverse design: how AI is redefining drug delivery systems
Sofía Blas-Gómez1, Carlos Alonso-Moreno2, Alberto Ocaña3
1Unidad nanoDrug, Facultad de Farmacia de Albacete, Departamento de Química Física, Universidad de Castilla-La Mancha, Albacete 02071, Spain.
None:
AI is transforming drug delivery system (DDS) design by enabling predictive modeling and inverse design strategies. Recent advances integrating machine learning, deep learning and physics-informed approaches have improved the ability to capture complex formulation-performance relationships. This review provides a structured overview of AI methodologies in DDS, compares their strengths and limitations, and discusses their integration into pharmaceutical pipelines. Key challenges, including data heterogeneity, limited generalizability, model interpretability and regulatory validation, are critically assessed as barriers to clinical translation of AI-driven DDS design.
Related Concept Videos
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Oral Drug Delivery Systems: Introduction
Drug Delivery Systems: Different Types
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Discovery: Overview
